Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Anika Therapeutics (ANIK) Asset Utilization Ratio: 2011-2025

Historic Asset Utilization Ratio for Anika Therapeutics (ANIK) over the last 13 years, with Sep 2025 value amounting to 0.60.

  • Anika Therapeutics' Asset Utilization Ratio rose 71.04% to 0.60 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.60, marking a year-over-year increase of 71.04%. This contributed to the annual value of 0.51 for FY2024, which is 29.97% up from last year.
  • Per Anika Therapeutics' latest filing, its Asset Utilization Ratio stood at 0.60 for Q3 2025, which was down 1.22% from 0.61 recorded in Q2 2025.
  • In the past 5 years, Anika Therapeutics' Asset Utilization Ratio ranged from a high of 0.61 in Q2 2025 and a low of 0.33 during Q4 2022.
  • Moreover, its 3-year median value for Asset Utilization Ratio was 0.40 (2023), whereas its average is 0.45.
  • In the last 5 years, Anika Therapeutics' Asset Utilization Ratio decreased by 23.22% in 2023 and then soared by 71.04% in 2025.
  • Anika Therapeutics' Asset Utilization Ratio (Quarterly) stood at 0.42 in 2021, then dropped by 22.59% to 0.33 in 2022, then increased by 23.50% to 0.40 in 2023, then skyrocketed by 36.91% to 0.55 in 2024, then soared by 71.04% to 0.60 in 2025.
  • Its last three reported values are 0.60 in Q3 2025, 0.61 for Q2 2025, and 0.60 during Q1 2025.